• Publications
  • Influence
Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions
  • M. Haas, B. Sis, +25 authors M. Mengel
  • Medicine
  • American journal of transplantation : official…
  • 1 February 2014
The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19–23, 2013, and was preceded by a 2‐day Latin American Symposium on Transplant Immunobiology andExpand
  • 929
  • 63
  • Open Access
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups
The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchersExpand
  • 680
  • 36
  • Open Access
C3 glomerulopathy: consensus report
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. InExpand
  • 350
  • 25
Sarcoidosis: the nephrologist's perspective.
  • 122
  • 19
Monomorphous Angiocentric Glioma: A Distinctive Epileptogenic Neoplasm With Features of Infiltrating Astrocytoma and Ependymoma
We present 8 examples of a neoplasm with features of both astrocytoma and ependymoma that may represent a distinct clinicopathologic entity. The cerebral hemispheric tumors occurred in patients thatExpand
  • 151
  • 18
  • Open Access
Antibody-mediated rejection in renal allografts: lessons from pathology.
The past 15 years have seen major advances in the understanding of the effects of anti-donor antibodies on renal allografts at various stages after transplantation. These advances have been due inExpand
  • 90
  • 10
  • Open Access
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
The 9th Banff Conference on Allograft Pathology was held in La Coruna, Spain on June 23–29, 2007. A total of 235 pathologists, clinicians and scientists met to address unsolved issues inExpand
  • 470
  • 9
  • Open Access
ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation
The requirements for potent immunosuppression coupled with the formidable risk of irreversible antibody-mediated rejection (AMR) have thus far limited the expansion of ABO incompatible (ABOi) kidneyExpand
  • 198
  • 8
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d‐negative antibody‐mediated rejection (ABMR)Expand
  • 297
  • 7
  • Open Access
Pros and cons for C4d as a biomarker.
The introduction of C4d in daily clinical practice in the late nineties aroused an ever-increasing interest in the role of antibody-mediated mechanisms in allograft rejection. As a marker ofExpand
  • 130
  • 7